Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Finished Goods Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Dna X (SONM) Current Leases (2022 - 2023)

Dna X's Current Leases history spans 2 years, with the latest figure at $55000.0 for Q4 2023.

Quarterly results put Current Leases at $55000.0 for Q4 2023, down 16.67% from a year ago — trailing twelve months through Dec 2023 was $55000.0 (down 16.67% YoY), and the annual figure for FY2023 was $55000.0, down 16.67%.
Current Leases for Q4 2023 was $55000.0 at Dna X, down from $120000.0 in the prior quarter.
In the past five years, Current Leases ranged from a high of $769000.0 in Q1 2022 to a low of $55000.0 in Q4 2023.